Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 16/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 15/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 13/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 13/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7725317 | 0.91 | PDE4A (0.38) | PDE4APDE4BPDE4CPDE4DS1PR1 | |
| SCHEMBL7737479 | 0.84 | PDE4A (0.45) | PDE4APDE4BPDE4CPDE4DS1PR1 | |
| SCHEMBL7735523 | 0.73 | S1PR1 (0.53) | PDE4APDE4BPDE4CPDE4DS1PR1 | |
| SCHEMBL7733971 | 0.73 | MAPT (0.46) | — | |
| SCHEMBL7734840 | 0.70 | PDE4A (0.40) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7734786 | 0.69 | PDE4B (0.41) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7734780 | 0.69 | PDE4A (0.44) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7403476 | 0.63 | PDE4A (0.57) | PDE4APDE4BPDE4CPDE4DS1PR1 | |
| SCHEMBL28333811 | 0.63 | PDE4B (0.47) | PDE4APDE4BPDE4CPDE4DS1PR1 | |
| SCHEMBL28333810 | 0.63 | PDE4B (0.47) | PDE4APDE4BPDE4CPDE4DS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372770-B1 | TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF | EURO-CELTIQUE, S.A. | 2002-04-16 | — | — | US | disclosed |